(Q35869964)

English

Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma

scientific article published in April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

10 August 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

end-stage liver disease

1 reference

based on heuristic

inferred from title

3

object named as

Peter Abt

1 reference

Europe PubMed Central

10 August 2017

author name string

David Goldberg

1

1 reference

Europe PubMed Central

10 August 2017

Benjamin French

2

1 reference

Europe PubMed Central

10 August 2017

Sandy Feng

4

1 reference

Europe PubMed Central

10 August 2017

Andrew M Cameron

5

1 reference

Europe PubMed Central

10 August 2017

publication date

1 April 2012

1 reference

Europe PubMed Central

10 August 2017

Liver Transplantation

1 reference

Europe PubMed Central

10 August 2017

18

1 reference

Europe PubMed Central

10 August 2017

4

1 reference

Europe PubMed Central

10 August 2017

434-443

1 reference

Europe PubMed Central

10 August 2017

MELD Exceptions and Rates of Waiting List Outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319293

27 July 2018

Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319293

27 July 2018

A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319293

27 July 2018

Disparities in liver transplantation before and after introduction of the MELD score

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319293

27 July 2018

Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319293

27 July 2018

The model for end-stage liver disease (MELD)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319293

27 July 2018

Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319293

27 July 2018

Model for end-stage liver disease (MELD) and allocation of donor livers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319293

27 July 2018

A model to predict survival in patients with end-stage liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319293

27 July 2018

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319293

27 July 2018

Analysis of longitudinal data to evaluate a policy change

1 reference

https://api.crossref.org/works/10.1002%2FLT.23394

21 January 2018

Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times

1 reference

https://api.crossref.org/works/10.1002%2FLT.23394

21 January 2018

Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319293

24 September 2018

Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3319293

24 September 2018

Organ Procurement and Transplantation Network--HRSA. Final rule with comment period

1 reference

https://pubmed.ncbi.nlm.nih.gov/22271656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22271656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system

1 reference

https://pubmed.ncbi.nlm.nih.gov/22271656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/LT.23394

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35869964&oldid=1857847891"